Can we predict short-term side effects of methylphenidate immediate-release?

International Journal of Psychiatry in Clinical Practice

Volumn 12, Issue 1, 2008, Pages 48-54

  Karabekiroglu, Koray ^a   Yazgan, Yanki M ^b,c   Dedeoglu, Ceyda ^d  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Kurupelit Kampüsü ^*

Author keywords

Adverse effects; Immediate release; Methylphenidate; Side effects

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ANOREXIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BARKLEY STIMULANTS SIDE EFFECTS RATING SCALE; CHILD; COMORBIDITY; CONNERS TEACHER RATING SCALE; CONVERSATION; CRYING; DAY DREAMING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DROWSINESS; DRUG RELEASE; EUPHORIA; FEMALE; HABIT; HEADACHE; HUMAN; IMMEDIATE DRUG RELEASE; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NIGHTMARE; PATHOLOGICAL CRYING; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; SADNESS; SEX DIFFERENCE; SIDE EFFECT; SLEEP DISORDER; STOMACH PAIN; SYMPTOMATOLOGY; TIC;

EID: 45849135555     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500701435954     Document Type: Article

References (26)

1. Weiss M, Weiss G. Attention-deficit/hyperactivity disorder. In: Lewis M, editor. Child and adolescent psychiatry: A comprehensive textbook. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p 645-70.
2. MTA Cooperative Group. 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86.
3. Stein MA, Blondis TA, Schnitzler ER, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996;98:748-56.
4. Adesman AR, Morgan AM. Management of stimulant medication in children with Attention Deficit/Hyperactivity Disorder. Pediatr Clin North Am 1999;46:945-63.
5. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit- hyperactivity disorder. New Engl J Med 1999;340:780-8.
6. Schachter HM, Pham B, Langford S, Moher D, King J. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J 2001;165:1475-88.
7. Barkley RA, McMurray M, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit disorder: A systemic, placebo-controlled evaluation. Pediatrics 1990;86(2):184-92.
8. DuPaul GJ, Barkley RA, Conner DF. Stimulants. In: Barkley RA, editor. Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press; 1998.
9. Accardo P, Blondis T. What's all the fuss about Ritalin? J Pediatr 2001;138:6-9.
10. Klein RG, Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988;45(12):1131-4.
11. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998;102:501-6.
12. Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res 2005;63(4):159-64.
13. Ercan ES, Amado S, Somer O, Cikoglu S. Dikkat eksikliǧi hiperaktivite bozukluǧu ve yikici davranim bozukluklari için bir test bataryasi geliştirme çabasi. Çocuk ve Gençlik Ruh Saǧliǧi Dergisi (Turkish J Child Adolesc Ment Health) 2001;8:132-45.
14. Conners CK. Rating Scales in attention-deficit/hyperactivity disorder Use in assessment and treatment monitoring. J Clin Psychiatry 1998;59(Suppl 7):24-30.
15. Sener Ş, Dereboy Ç, Dereboy F, et al. Conners öǧretmen derecelendirme ölçeǧi Türkçe uyarlamasi-1. Çocuk ve Gençlik Ruh Saǧliǧi Dergisi (Turkish J Child Adolesc Ment Health) 1995;2(3):131-42.
16. Dereboy C, Sener S, Dereboy IF, et al. Conners öǧretmen derecelendirme ölçeǧi Türkçe uyarlamasi-2. Çocuk ve Gençlik Ruh Saǧliǧi Dergisi (Turkish J Child Adolesc Ment Health) 1997;4:10-8.
17. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for schoolage children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-8.
18. Gökler B, Unal F, Pehlivanturk B, et al. Okul çaǧi çocuklari için duygulanim bozukluklari ve şizofreni görüşme çizelgesis ̧imdi ve yaşam boyu şekli-Türkçe uyarlamasinin geçerlik ve güvenirliǧi. Çocuk ve Gençlik Ruh Saǧliǧ i Dergisi (Turkish J Child Adolesc Ment Health) 2004;11(3):109-16.
19. Barkley RA, editor. Attention-deficit hyperactivity disorder. A handbook for diagnosis and treatment. 2nd ed. New York: The Guilford Press; 1998.
20. Greydanus DE, Pratt HD, Sloane MA, Rappley MD. Attention-deficit/ hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum. Pediatr Clin North Am 2003;50(5):1049-92.
21. Wender EH. Managing stimulant medication for attention-deficit/ hyperactivity disorder. Pediatr Rev 2001;22(6):183-90.
22. Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA. Effects of late-afternoon methylphenidate administration on behavior and sleep in ADHD. Pediatrics 1995;96:320-5.
23. Owens JA, Maxim R, Nobile C, McGuinn M, Msall M. Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2000;/154(6):/549-55.
24. Sverd J. Methylphenidate treatment for children with attention deficit hyperactivity disorder and tic disorder: Inadvisable or indispensable? In: Greenhill LL, Osman BB, editors. Ritalin: Theory and practice, 2nd ed. Larchmont, NY: Mary Ann Liebert, Inc; 2000. p 301-19.
25. Bennett FC, Brown RT, Craver J, Anderson D. Stimulant medication for the child with attention-deficit hyperactivity disorder. Pediatr Clin North Am 1999;46:929-43.
26. Johnston C, Pelham WE, Hoza J, Sturges J. Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 1988;27:806-10.